| Name | LTD4 antagonist 1 |
|---|---|
| Synonyms |
1H-Indole-5-cboxamide, 3-[[2-methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-N-(4,4,4-trifluoro-2-methylbutyl)
LTD4 antagonist 1,LTD-4 antagonist 1 |
| Description | LTD4 antagonist 1 is a potent, orally active antagonist of leukotriene D4 (LTD4) with a Ki of 0.57 nM. |
|---|---|
| Related Catalog | |
| Target |
LTD4:0.57 nM (Ki) |
| In Vitro | LTD4 antagonist 1 (Compound 38b) exhibits a Ki of 0.57 nM for displacement of [3H]LTD4 on guinea pig lung membranes, a pKB of 9.93±0.14 versus LTE4 on guinea pig trachea[1]. |
| In Vivo | LTD4 antagonist 1 (Compound 38b) exhibits a po ED50/iv ED50 of 1.44 and 0.036 μmol/kg in LTD4-induced bronchoconstriction in guinea pigs[1]. |
| References |
| Molecular Formula | C31H32F3N3O5S |
|---|---|
| Molecular Weight | 615.66 |